5-Chloro-6-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 95%, 100mg

4,5-dimethyl-2-pyrimidinamine, 95.0%, 1g

2-(2-Fluoro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 25g

3-Ethoxy-3-oxopropanoic acid, 98%, 100g

6-Chloro-2,4-difluoroiodobenzene, 1g

Slide with phase contrast cancellation 40x for Abbe condenser with opening for bScope. Needs condenser with orifice (BS.9102)

1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide hydrochloride, 95.0%, 250mg

(1-(Trifluoromethyl)cyclopropyl)methyl methanesulfonate, 1g

Ethyl 2-iodooxazole-4-carboxylate, 95.0%, 10g

1-Ethyl-3-methyl-imidazolium-dicyanamide, min. 98%, 25 g, glass packaging

6,6-DIMETHYL-4,5,6,7-TETRAHYDRO-1H-INDAZOLE-3-CARBOXYLIC ACID, 95.0%, 500mg

tert-Butyl 6-chloro-3-formylpyridin-2-ylcarbamate, 95.0%, 1g